Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): A dose-finding study and pharmacogenomic analysis

1. Zarate, R.
2. Rodríguez, J.
3. Bandres, E.
4. Patĩo-Garcia, A.
5. Ponz-Sarvise, M.
6. Viudez, A.
7. Ramirez, N.
8. Bitarte, N.
9. Chopitea, A.
10. Gacía-Foncillas, J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1038/SJ.BJC.6605595 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus